Snapdragon Chemistry
Acquisition in 2022
Snapdragon Chemistry is a company based in Waltham, Massachusetts, focused on developing continuous flow chemistry solutions for the production of active pharmaceutical ingredients, intermediates, and materials. Founded in 2014, the company offers services including process development, reactor design and build, portfolio optimization, and GMP manufacturing. Snapdragon Chemistry addresses complex chemical transformations to create scalable synthetic processes for clients in pharmaceuticals, chemicals, animal care, and material science industries. The company was previously known as Firefly Chemistry before changing its name in April 2015.
Q1 Scientific
Acquisition in 2022
Q1 Scientific specializes in providing environmentally controlled stability storage services tailored for the pharmaceutical, medical device, and life sciences sectors. The company offers outsourced stability storage and sample management solutions that ensure a safe and secure environment for critical samples. By utilizing Q1 Scientific's services, clients can enhance the efficiency of their operations, thereby accelerating the development of new drugs and reducing the costs associated with constructing and maintaining their own storage facilities.
Avista Pharma
Acquisition in 2018
Avista Pharma Solutions is a contract testing, development, and manufacturing organization that operates across three locations in Agawam, Massachusetts; Durham, North Carolina; and Longmont, Colorado. The company provides a wide range of services to clients in the pharmaceutical, animal health, and medical device sectors. These services include early drug development, active pharmaceutical ingredient (API) and drug product development, as well as compliant Good Manufacturing Practice (cGMP) manufacturing. Additionally, Avista offers standalone analytical and microbiology testing support, facilitating the development of newly created medicinal drugs. With over 200,000 square feet of laboratory and manufacturing space, Avista Pharma Solutions plays a vital role in the lifecycle of drug development and testing.
Halo Pharmaceutical
Acquisition in 2018
Halo Pharmaceutical, located in Whippany, New Jersey, specializes in contract dosage form development, manufacturing, and testing services for the pharmaceutical, biotechnology, and generic sectors. The company provides a comprehensive range of capabilities across various dosage forms, including tablets, capsules, powders, liquids, creams, and both sterile and nonsterile ointments and suppositories. By focusing on quality and efficiency, Halo Pharmaceutical aims to support its clients in delivering innovative healthcare solutions to improve patient outcomes.
PharmaCore
Acquisition in 2016
PharmaCore is a prominent partner in small molecule drug discovery, development, and manufacturing, catering to pharmaceutical and biotechnology companies. The company offers a comprehensive suite of services that spans the entire drug discovery process, including lead discovery, lead optimization, chemical synthesis, and the scale-up of pharmaceutical intermediates. PharmaCore excels in custom organic synthesis, utilizing a range of chemistries to produce active pharmaceutical ingredients and scaffolds. It operates GMP manufacturing facilities capable of scaling up production from grams to multi-kilogram quantities, featuring eight GMP production areas equipped with reactors up to 2000 liters. To ensure compliance with FDA and international regulations, PharmaCore has a dedicated Quality Assurance department. Additionally, the company provides state-of-the-art analytical services, including a diverse array of testing capabilities and experienced methods development and validation. PharmaCore is licensed to manufacture controlled substances and has expertise in the logistics management of regulated materials, making it a valuable extension of its clients' chemistry teams through both short and long-term contract research programs.
Xcellsyz
Acquisition in 2006
Xcellsyz is a biotechnology company, focusses on the discovery of new drugs.